InfuSystem Holdings (INFU) Profit After Tax (2010 - 2026)
InfuSystem Holdings (INFU) posted Profit After Tax of $1.0 million for Q1 2026, down 47.58% on a QoQ basis from $2.0 million in Q4 2025, and up 484.64% year-over-year from $175662.4 in Q1 2025.
InfuSystem Holdings (INFU) Profit After Tax (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Profit After Tax history runs 17 years deep, the most recent figure standing at $1.0 million for Q1 2026.
- Quarterly Profit After Tax rose 484.64% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.6 million (up 175.74% YoY) and the FY2025 annual result came in at $6.1 million, up 155.6% from the prior year.
- Profit After Tax was $1.0 million for Q1 2026 at InfuSystem Holdings, down from $2.0 million in the prior quarter.
- Across five years, Profit After Tax topped out at $2.4 million in Q2 2025 and bottomed at -$904000.0 in Q1 2024.
- A 5-year average of $645529.4 and a median of $689000.0 in 2023 frame the typical range for Profit After Tax.
- Peak annual rise in Profit After Tax reached 2790.48% in 2023, while the deepest fall reached 2157.14% in 2023.
- InfuSystem Holdings' Profit After Tax stood at -$21000.0 in 2022, then tumbled by 2157.14% to -$474000.0 in 2023, then soared by 303.38% to $964000.0 in 2024, then jumped by 103.22% to $2.0 million in 2025, then slumped by 47.58% to $1.0 million in 2026.
- Business Quant data shows INFU's Profit After Tax at $1.0 million in Q1 2026, $2.0 million in Q4 2025, and $2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 1.08 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 745.00 Mn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.34 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 380.70 Mn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 199.50 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 411.00 Mn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 170.93 Mn |
| 10 | InfuSystem Holdings | 188.97 Mn | 186.87 Mn | 19.68 Mn | 1.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.03 Mn |
| Dec 31, 2025 | 1.96 Mn |
| Sep 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 2.45 Mn |
| Mar 31, 2025 | -267,000.00 |
| Dec 31, 2024 | 964,000.00 |
| Sep 30, 2024 | 1.35 Mn |
| Jun 30, 2024 | 717,000.00 |
| Mar 31, 2024 | -904,000.00 |
| Dec 31, 2023 | -474,000.00 |
| Sep 30, 2023 | 689,000.00 |
| Jun 30, 2023 | 607,000.00 |
| Mar 31, 2023 | -543,000.00 |
| Dec 31, 2022 | -21,000.00 |
| Sep 30, 2022 | 902,000.00 |
| Jun 30, 2022 | 21,000.00 |
| Mar 31, 2022 | 319,000.00 |
| Dec 31, 2021 | -765,000.00 |
| Sep 30, 2021 | -448,000.00 |
| Jun 30, 2021 | 820,000.00 |